Table 3.
Characteristics | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | p value | 95% CI | HR | p value | 95% CI | |
Sex (female vs male) | 1.264 | 0.597 | 0.529–3.019 | |||
Age (<60 vs ≥60) | 1.705 | 0.214 | 0.735–3.953 | |||
Differentiation (well+moderate vs poor) | 1.651 | 0.242 | 0.713–3.827 | |||
Tumor Size (<5 vs ≥5) | 2.284 | 0.056 | 0.980–5.326 | |||
TNM stage (I, II vs III, IV) | 5.322 | 0.003 | 1.780–15.913 | 4.480 | 0.008 | 1.473–13.625 |
Nerves (negative vs positive) | 2.291 | 0.137 | 0.768–6.829 | |||
Vessels (negative vs positive) | 1.067 | 0.888 | 0.433–2.628 | |||
Lymph node (N0-1 vs N2-3) | 1.562 | 0.333 | 0.633–3.853 | |||
Tumor site (Antrum vs Cardia) | 1.079 | 0.874 | 0.420–2.773 | |||
miR-140-3p level (high vs low) | 2.700 | 0.041 | 1.043–6.990 | 1.294 | 0.636 | 0.446–3.755 |
BCL2 level (low vs high) | 2.836 | 0.019 | 1.183–6.799 | 2.112 | 0.098 | 0.870–5.126 |
Note: p<0.05 is indicated present in bold.
Abbreviations: TNM, tumor-node-metastasis; HR, hazard ratio; CI, confidence interval; high, high expression; low, low expression.